Andorra vs Grenada: Tuberculosis patients living with HIV receiving antiretroviral therapy
Andorra
0 patients
in 2021
Grenada
0 patients
in 2021
Andorra rank
141st
Grenada rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Andorra
- Grenada
How they compare
Andorra currently reports 0 patients against 0 patients in Grenada, a difference of 0 patients.
Across all 13 years both countries report, Grenada has been ahead every year.
Andorra ranks 141st and Grenada ranks 141st of 183 countries.
Grenada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0.75 patients | 0.75 patients | Grenada |
| 2010s | 0 patients | 0.5714 patients | 0.5714 patients | Grenada |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Andorra or Grenada?
- Andorra, at 0 patients against 0 patients in Grenada as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Andorra and Grenada?
- 0 patients, with Andorra ahead.
- How many years of comparable data are there for Andorra and Grenada?
- 13 years are reported by both, from 2003 to 2021.
- How do Andorra and Grenada rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Andorra ranks 141st and Grenada ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.